These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18482837)

  • 21. LEA3D: a computer-aided ligand design for structure-based drug design.
    Douguet D; Munier-Lehmann H; Labesse G; Pochet S
    J Med Chem; 2005 Apr; 48(7):2457-68. PubMed ID: 15801836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinatorial and computational approaches in structure-based drug design.
    Kubinyi H
    Curr Opin Drug Discov Devel; 1998 Jul; 1(1):16-27. PubMed ID: 19649785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DASH: a novel analysis method for molecular dynamics simulation data. Analysis of ligands of PPAR-gamma.
    Salt DW; Hudson BD; Banting L; Ellis MJ; Ford MG
    J Med Chem; 2005 May; 48(9):3214-20. PubMed ID: 15857127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of a virtual combinatorial library using SMILES strings to discover potential structure-diverse PPAR modulators.
    Liao C; Liu B; Shi L; Zhou J; Lu XP
    Eur J Med Chem; 2005 Jul; 40(7):632-40. PubMed ID: 15935898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists.
    Lin CH; Peng YH; Coumar MS; Chittimalla SK; Liao CC; Lyn PC; Huang CC; Lien TW; Lin WH; Hsu JT; Cheng JH; Chen X; Wu JS; Chao YS; Lee HJ; Juo CG; Wu SY; Hsieh HP
    J Med Chem; 2009 Apr; 52(8):2618-22. PubMed ID: 19301897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The discovery of equipotent PPARalpha/gamma dual activators.
    Martres P; Faucher N; Laroze A; Pineau O; Fouchet MH; Potvain F; Grillot D; Beneton V
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6251-4. PubMed ID: 18947994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARalpha/gamma dual agonists.
    Kim E; Park CS; Han T; Bae MH; Chong W; Lee CH; Shin YA; Ahn BN; Kim MK; Shin CY; Son MH; Kim JK; Moon HS; Shim HJ; Kim EJ; Kim SH; Lim JI; Lee CH
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4993-6. PubMed ID: 18771917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A short series of antidiabetic sulfonylureas exhibit multiple ligand PPARgamma-binding patterns.
    Arrault A; Rocchi S; Picard F; Maurois P; Pirotte B; Vamecq J
    Biomed Pharmacother; 2009 Jan; 63(1):56-62. PubMed ID: 18280694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonists.
    Suh YG; Kim NJ; Koo BW; Lee KO; Moon SH; Shin DH; Jung JW; Paek SM; Chang DJ; Li F; Kang HJ; Le TV; Chae YN; Shin CY; Kim MK; Lim JI; Ryu JS; Park HJ
    J Med Chem; 2008 Oct; 51(20):6318-33. PubMed ID: 18826205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
    Matin A; Gavande N; Kim MS; Yang NX; Salam NK; Hanrahan JR; Roubin RH; Hibbs DE
    J Med Chem; 2009 Nov; 52(21):6835-50. PubMed ID: 19807106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonists.
    Zhang H; Ryono DE; Devasthale P; Wang W; O'Malley K; Farrelly D; Gu L; Harrity T; Cap M; Chu C; Locke K; Zhang L; Lippy J; Kunselman L; Morgan N; Flynn N; Moore L; Hosagrahara V; Zhang L; Kadiyala P; Xu C; Doweyko AM; Bell A; Chang C; Muckelbauer J; Zahler R; Hariharan N; Cheng PT
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1451-6. PubMed ID: 19201606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line.
    Pérez-Sacau E; Díaz-Peñate RG; Estévez-Braun A; Ravelo AG; García-Castellano JM; Pardo L; Campillo M
    J Med Chem; 2007 Feb; 50(4):696-706. PubMed ID: 17249647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on quinones. Part 43: Synthesis and cytotoxic evaluation of polyoxyethylene-containing 1,4-naphthoquinones.
    Valderrama JA; Leiva H; Rodríguez JA; Theoduloz C; Schmeda-Hirshmann G
    Bioorg Med Chem; 2008 Apr; 16(7):3687-93. PubMed ID: 18299197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer-aided design of chiral ligands. Part III. A novel ligand for asymmetric allylation designed using computational techniques.
    Kozlowski MC; Waters SP; Skudlarek JW; Evans CA
    Org Lett; 2002 Dec; 4(25):4391-3. PubMed ID: 12465895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel alpha-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure.
    Park H; Hwang KY; Oh KH; Kim YH; Lee JY; Kim K
    Bioorg Med Chem; 2008 Jan; 16(1):284-92. PubMed ID: 17920282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of Hydroxy-1,4-naphthoquinone Derivatives on Prostaglandin synthesis (author's transl)].
    Wurm G; Baumann J
    Arzneimittelforschung; 1981; 31(10):1673-7. PubMed ID: 7198443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and structure-activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands.
    Okubo T; Yoshikawa R; Chaki S; Okuyama S; Nakazato A
    Bioorg Med Chem; 2004 Jul; 12(13):3569-80. PubMed ID: 15186841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and docking studies of new 1,4-dihydropyridines containing 4-(5)-Chloro-2-ethyl-5-(4)-imidazolyl substituent as novel calcium channel agonist.
    Davood A; Nematollahi AR; Iman M; Shafiee A
    Arch Pharm Res; 2009 Apr; 32(4):481-7. PubMed ID: 19407963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 6-Aryl-4-methylsulfanyl-2H-pyran-2-one-3-carbonitriles as PPAR-gamma activators.
    Sharon A; Pratap R; Vatsyayan R; Maulik PR; Roy U; Goel A; Ram VJ
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3356-60. PubMed ID: 15953723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.